• Drosophila Keap1–Lamin Dm0 and Nuclear Architecture

  2026-09-10

  Carlson and colleagues identify a molecular and genetic relationship between Drosophila Keap1 and the B-type lamin Dm0, connecting xenobiotic-response signaling with nuclear lamina organization and heterochromatin distribution. Their combination of localization, chromatin-marker, morphology, and genetic-interaction analyses suggests that dKeap1 can influence developmental phenotypes through higher-order nuclear architecture.

• Capecitabine in Gastric Cancer Assembloids

  2026-09-10

  Capecitabine can help interrogate prodrug activation, stromal drug resistance, and apoptosis in patient-derived gastric cancer assembloids. This article presents a decision-focused framework for separating tumor-selective metabolism from microenvironment-driven response changes.

• BAY-826: Angiogenesis and Retinal Signaling Research

  2026-09-09

  BAY-826 is a potent small molecule inhibitor with a reported IC50 of 1.6 nM. Its use in angiogenesis and retinal neuron-survival experiments should be treated as a pharmacological research strategy, because the cited retinal study establishes Ang/Tie-2/PEDF biology but does not directly report BAY-826 testing.

• Resiniferatoxin (RTX) for TRPV1 Pain Research

  2026-09-09

  Resiniferatoxin (RTX) converts intense TRPV1 activation into a controlled model of sensory-neuron desensitization, making it valuable for pain, inflammation, and calcium-signaling studies. This workflow-focused guide covers assay setup, route selection, cyclodextrin-based membrane experiments, and troubleshooting for translational pain research.

• TDRD9 siRNA Nanoparticles in P. aeruginosa Lung Injury

  2026-09-08

  The reference study identifies TDRD9 as a suppressor of neutrophil cuproptosis and develops hyaluronic acid-coated peptide nanoparticles to deliver TDRD9 siRNA during Pseudomonas aeruginosa lung infection. Evidence from patient-derived neutrophils, mouse models, and human lung organoids connects TDRD9 silencing with reduced neutrophil accumulation, bacterial burden, inflammation, and tissue injury through the PD-L1/CD80/p38 MAPK axis.

• Capecitabine in Patient-Derived Tumor Assays

  2026-09-08

  Capecitabine is a tumor-activated fluoropyrimidine prodrug whose apparent activity can change when stromal cells are added to patient-derived models. This article explains how gastric cancer assembloids can improve assay design, mechanism-focused readouts, and translational interpretation.

• Oteseconazole (VT-1161) in Candida Research

  2026-09-07

  Oteseconazole (VT-1161) is a selective tetrazole CYP51 inhibitor suited to Candida susceptibility testing, resistant-isolate profiling, and mechanism-focused antifungal research. This workflow-oriented guide covers dilution design, controls, assay interpretation, troubleshooting, and how to translate planktonic results into more advanced antifungal studies.

• Resiniferatoxin (RTX) Workflows for TRPV1 Research

  2026-09-07

  Resiniferatoxin (RTX) provides a precision workflow for activating, functionally silencing, and validating TRPV1-positive sensory pathways. This guide translates its ultra-potent pharmacology into calcium-imaging, tissue, and translational pain assays while showing how a recent GERD study used RTX as a mechanistic validation tool.

• Oteseconazole: From MIC to DDI-Aware Assays

  2026-09-05

  Oteseconazole (VT-1161) is a selective tetrazole CYP51 inhibitor whose value extends beyond low Candida MICs. This article presents a DDI-aware assay framework that connects fungal potency, resistance testing, formulation, and transporter risk without confusing in vitro activity with clinical effectiveness.

• Methylprednisolone Sodium Succinate: Bench Workflows

  2026-09-04

  Build reproducible corticosteroid experiments with concentration controls, vehicle matching, and orthogonal inflammatory readouts. This guide translates product specifications and receptor-pharmacology principles into practical workflows for inflammation, immunology, leukocyte, and tumor-cell studies.

• CCK-8 Workflow for APL Cell Response Studies

  2026-09-04

  Build a practical CCK-8 workflow for measuring APL cell growth, drug response, and cytotoxicity without confusing metabolic activity with cell number. This guide translates retinoid-receptor findings into plate design, controls, dose-response analysis, and troubleshooting decisions.

• Dual-Network Microspheres for Disc Degeneration

  2026-09-03

  The reference study develops an elastic dual-network hydrogel microsphere that combines stimulus-responsive miRNA delivery with local inflammatory modulation for intervertebral disc degeneration. Its design links mechanical durability, oxidative-environment-triggered release, CD44-mediated cellular uptake, and coordinated control of apoptosis and intracellular oxidative stress.

• Gastrin I (human): Reliable Assay Workflows

  2026-09-03

  This scenario-driven guide shows how Gastrin I (human), SKU B5358, can improve experimental planning for viability, proliferation, cytotoxicity, and gastric acid secretion studies. It connects peptide handling, organoid-model selection, and orthogonal data interpretation to practical laboratory decisions.

• Hematoxylin and Eosin Staining Kit Guide

  2026-09-02

  The Hematoxylin and Eosin Staining Kit (SKU K1142) provides ready-to-use hematoxylin and eosin solutions for consistent tissue morphology visualization in paraffin-embedded, frozen, and cytological samples. It is intended for research workflows and morphological assessment only, not for diagnosis, clinical decisions, or regulated medical use.

• Hexose Diphosphate in Metabolic Assays

  2026-09-02

  Hexose diphosphate supports practical studies of glycolytic control, ischemic energy failure, and inflammation-linked metabolic remodeling. This workflow-focused guide explains how to prepare the water-soluble hexose phosphate, design interpretable cell and tissue assays, and distinguish its effects from the phosphoenolpyruvate mechanism reported in healthy-aging research.

7797 records 1/520 page Next 12345 下5页 Last page